Target Name: CEMP1
NCBI ID: G752014
Review Report on CEMP1 Target / Biomarker Content of Review Report on CEMP1 Target / Biomarker
CEMP1
Other Name(s): Cementum protein 1 | CP-23 | Cementoblastoma-derived protein 1 | Cementum protein-23 | cementum protein 23 | CEMP1_HUMAN | CP23 | cementum protein 1 | Cementum protein 23

Cementum Protein 1: Potential Drug Target Or Biomarker

Cementum protein 1 (CEMP1) is a protein that is expressed in a variety of tissues throughout the body, including bone, cartilage, and various organs. It is a member of the cementum family of proteins, which are characterized by the presence of a unique C-terminal domain that is composed of a series of amino acids that are similar to those found in actinin.

CEMP1 is unique among its family members because of its ability to interact with a variety of different signaling molecules. This has led to its potential as a drug target or biomarker.

One of the ways that CEMP1 is involved in signaling is through its role in the regulation of cell adhesion. CEMP1 is a negative regulator of cell adhesion, which means that it helps to keep cells in place by preventing them from moving away from each other. This is important for the development and maintenance of tissues and organs, as cells that are able to stick together are better able to perform their functions.

Another way that CEMP1 is involved in signaling is through its role in the regulation of signaling pathways. CEMP1 has been shown to be involved in a variety of signaling pathways, including the TGF-β pathway and the Wnt pathway. These pathways are important for the development and maintenance of tissues and organs, and CEMP1 may be a key regulator of these processes.

In addition to its role in signaling, CEMP1 is also involved in the regulation of cellular processes such as cell division and apoptosis. CEMP1 has been shown to be involved in the regulation of cell division, as well as the process of apoptosis. This is important for the development and maintenance of tissues and organs, as cells that are able to divide and die properly are essential for their function.

CEMP1 is also involved in the regulation of the immune response. CEMP1 has been shown to be involved in the regulation of immune cell function, as well as the production of antibodies. This is important for the immune system, as antibodies are important for protecting the body against the presence of harmful pathogens.

In conclusion, CEMP1 is a protein that is involved in a variety of signaling pathways and is involved in the regulation of cellular processes such as cell division, apoptosis, and the immune response. Its unique ability to interact with a variety of different signaling molecules makes it a potential drug target or biomarker. Further research is needed to fully understand the role of CEMP1 in these processes and to determine its potential as a therapeutic agent.

Protein Name: Cementum Protein 1

Functions: May play a role in development of the periodontium which surrounds and supports the teeth by promoting the differentiation of multi-potent cells from the periodontal ligament into cementoblasts to form the cementum (PubMed:21929512, PubMed:17509525, PubMed:21465469). Binds hydroxyapatite and may promote the biomineralization of the cementum (PubMed:19393626). Also promotes cell proliferation (PubMed:17509525, PubMed:21929512, PubMed:26011628)

The "CEMP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEMP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CENATAC | CEND1 | CENP-A-nucleosome distal (CAD) centromere complex | CENPA | CENPA-CAD (nucleosome distal) complex | CENPA-NAC (nucleosome-associated) complex | CENPB | CENPBD1P | CENPBD2P | CENPC | CENPCP1 | CENPE | CENPF | CENPH | CENPI | CENPIP1 | CENPJ | CENPK | CENPL | CENPM | CENPN | CENPO | CENPP | CENPQ | CENPS | CENPS-CORT | CENPT | CENPU | CENPV | CENPVL1 | CENPW | CENPX | Centralspindlin complex | CEP104 | CEP112 | CEP120 | CEP126 | CEP128 | CEP131 | CEP135 | CEP152 | CEP162 | CEP164 | CEP170 | CEP170B | CEP170P1 | CEP19 | CEP192 | CEP20 | CEP250 | CEP290 | CEP295 | CEP295NL | CEP350 | CEP350-FGFR1OP-MAPRE1 complex | CEP41 | CEP43 | CEP44 | CEP55 | CEP57 | CEP57L1 | CEP63 | CEP68 | CEP70 | CEP72 | CEP72-DT | CEP76 | CEP78 | CEP83 | CEP83-DT | CEP85 | CEP85L | CEP89 | CEP95 | CEP97 | CEPT1 | CER1 | Ceramidase | Ceramide synthase | CERCAM | CERK | CERKL | CERNA2 | CERS1 | CERS2 | CERS3 | CERS3-AS1 | CERS4 | CERS5 | CERS6 | CERS6-AS1 | CERT1 | CES1 | CES1P1 | CES1P2 | CES2 | CES3 | CES4A | CES5A | CETN1